Skip to content

TEM

Tempus AI, Inc.

NASDAQ · USHealthcareMedical - Healthcare Information Services
$48.41-7.74%

Price as of Jul 20, 2026

TEM growth

Tempus AI, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+69.8%
EBITDA
+78.9%
EBIT
+65.0%
EPS
+62.8%
Free cash flow
-1.8%
Operating cash flow
+3.9%

Forward estimates

Revenue
+28.0%
EBITDA
EPS
+85.6%

Three-year CAGR

Revenue
+58.3%
EBITDA
+63.6%
EBIT
+65.5%
Net income
+65.3%
EPS
+69.3%
Free cash flow
-13.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.